{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:02:04Z","timestamp":1781010124320,"version":"3.54.1"},"update-to":[{"DOI":"10.3389\/fonc.2026.1680081","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000}}],"reference-count":0,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2026.1886923","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:07:11Z","timestamp":1781006831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction: Phase I\/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors"],"prefix":"10.3389","volume":"16","author":[{"given":"Darren","family":"Hargrave","sequence":"first","affiliation":[{"name":"University College London Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynley V.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Pediatric and Adolescent Oncology Drug Development Unit, Oak Centre for Children and Young People, The Royal Marsden Hospital and Division of Clinical Studies, The Institute of Cancer Research","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology Department, H\u00f4pital pour Enfant de La Timone, Assistance Publique - H\u00f4pitaux de Marseille (AP-HM), and Reverse Molecular Pharmacology in Pediatric Oncology, Centre de Recherche en Canc\u00e9rologie de Marseille (CRCM), Aix-Marseille Universit\u00e9, CNRS, INSERM","place":["Marseille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Krystal","sequence":"additional","affiliation":[{"name":"Zucker Hofstra School of Medicine, Department of Pediatrics, Cohen Children\u2019s Medical Center","place":["New Hyde Park, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Ladle","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Robbins","sequence":"additional","affiliation":[{"name":"Global Patient Safety, Oncology, AstraZeneca","place":["Gaithersburg, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Hois","sequence":"additional","affiliation":[{"name":"Late-stage Development Oncology R&D, AstraZeneca","place":["Gaithersburg, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Oncology Biometrics","place":["AstraZeneca, Cambridge, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Donegan","sequence":"additional","affiliation":[{"name":"Oncology R&D, AstraZeneca","place":["Gaithersburg, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,9]]},"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1886923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:07:11Z","timestamp":1781006831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1886923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":0,"alternative-id":["10.3389\/fonc.2026.1886923"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1886923","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"1886923"}}